Pfizer: Downgrade
Charlotte (www.aktiencheck.de) - Rating-Update:
Geoff Meacham, Analyst von BofA Securities, stuft die Aktie des Pharma-Giganten Pfizer Inc. (ISIN: US7170811035, WKN: 852009,…
24,698€
3,86%
Echtzeit-Aktienkurs Pfizer Inc.
Bid:
Ask:
Nachrichten zur Pfizer Inc. Aktie
As COVID vaccine and Paxlovid sales decline, analysts want to know what’s next for Pfizer
Bank of America analysts downgraded the stock to neutral from buy...…
Merck Vs. Pfizer: Why Analyst Upgrades One Pharmaceutical Stock, While Downgrading Another
The health care sector held up relatively well in a difficult year for stocks in 2022. On Wednesday, one analyst…
Why Pfizer (PFE) Could Beat Earnings Estimates Again
Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…
Serie: Branchenausblick: Die Pharmaindustrie steht nach dem Corona-Boom vor einer Wachstumsdelle
Der Schub durch Covid-Impfstoffe und Medikamente flaut ab, gleichzeitig läuft für einige Produkte der Patentschutz ab. Novo Nordisk löst Pfizer…
Pfizer (PFE) Gains As Market Dips: What You Should Know
In the latest trading session, Pfizer (PFE) closed at $51.26, marking a +0.04% move from the previous day....…
BioNTech: Bundesregierung bemüht sich, überschüssige Impfstofflieferungen zu reduzieren - Aktienanalyse
Kulmbach (www.aktiencheck.de) - BioNTech-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von BioNTech SE (ISIN: US09075V1026,…
Tuesday’s Top Analyst Upgrades and Downgrades: Ally Financial, Apple, Block, DR Horton, EOG, Ford, Micron, PayPal, Pfizer and More
Tuesdays top analyst upgrades and downgrades included Ally Financial, Apple, Ardelyx, Block, DocuSign, D.R. Horton, Enovix, EOG Resources, Ford, Futu,…
BioNTech: Abnahmeverpflichtung für 375 Millionen Dosen Impfstoff
Deutschland hat sich insgesamt verpflichtet, etwa 375 Millionen Dosen Corona-Impfstoff von BioNTech und dem dazugehörigen amerikanischen Pharma-Partner Pfizer abzunehmen. Das…
Abnahmeverpflichtung für 375 Millionen Dosen Biontech-Impfstoff
BERLIN (dpa-AFX) - Deutschland hat sich insgesamt verpflichtet, etwa 375 Millionen Dosen Corona-Impfstoff von Biontech (BioNTech (ADRs))/Pfizer (Pfizer) abzunehmen. Das…
Global Bronchitis Treatments (Acute, Chronic) Market Report 2022-2027 Featuring Leading Players - AstraZeneca, Bayer, Cipla, Sanofi and Pfizer
DUBLIN, Dec. 30, 2022 /PRNewswire/ -- The "Bronchitis Treatments: Global Markets" report has been added to ResearchAndMarkets.coms offering. This study…
Pfizer: Die Daten der Hämophilie-Gentherapie "konkurrenzfähig" - Aktienanalyse
San Francisco (www.aktiencheck.de) - Pfizer-Aktienanalyse von Analyst Mohit Bansal von Wells Fargo Advisors:
Mohit Bansal, Analyst von Wells Fargo Advisors, stuft…
Drugmakers Spent Freely in 2022 to Protect Revenue
Pfizer, Amgen and Bristol-Myers Squibb bought makers of proven drugs ahead of potential rising competition from generics....…
China-Developed Covid Pill Matches Paxlovid, Study Shows
A China-developed Covid antiviral pill appeared to be as effective as Pfizer Inc.s Paxlovid with fewer safety concerns, according to…
Pfizer (PFE) Pentavalent Meningitis Jab BLA Gets FDA Acceptance
The FDA assigns a standard review to Pfizers (PFE) BLA for pentavalent meningococcal vaccine candidate (MenABCWY), with a decision expected…
Pfizer Announces Positive Results From Late-stage Study Of Hemophilia B Gene Therapy Candidate
NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) announced positive results from the Phase 3 BENEGENE-2 study (NCT03861273) evaluating fidanacogene…
Pfizer’s hemophilia B treatment meets primary endpoint in Phase 3 study
Pfizer Inc. said Thursday that a Phase 3 study of fidanacogene elaparvovec for the treatment of hemophilia B in adult…
Pfizer says hemophilia B gene therapy met key goal in Phase 3 trial
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pfizer Hemophilia Gene Therapy Hits Goal in Final-Stage Study
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pfizer: FDA Accepts For Review BLA For Pentavalent Meningococcal Vaccine Candidate In Adolescents
NEW YORK CITY (dpa-AFX) - The U.S. Food and Drug Administration accepted for review a Biologics License Application or BLA…
Pfizer: Die Kassen weiter prall gefüllt - M&A-Aktivitäten 2023 auf hohem Niveau erwartet - Aktienanalyse
Kulmbach (www.aktiencheck.de) - Pfizer-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Pfizer Inc. (ISIN: US7170811035,…
BioNTech-Partner Pfizer: Umsatz- und Gewinneinbruch erwartet
Der Pharma-Riese hat durch die Corona-Pandemie eine Sonderkonjunktur erfahren. Neben dem Covid-19-Medikament Paxlovid sorgte auch der Vertrieb der Corona-Impfstoffe mit…
4 stocks to watch on Wednesday: Apple, Pfizer and more
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Hormone Replacement Therapy Global Market Report 2022: Merck, Bayer, Pfizer, Abbott, Novartis, Novo Nordisk, Amgen, F. Hoffmann-La Roche & Eli Lilly
DUBLIN, Dec. 28, 2022 /PRNewswire/ -- The "Hormone Replacement Therapy Market, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation,…
Covid-19: Brazil’s Ministry of Health releases Pfizer vaccine for all children from 6 months to 4 years
Brazils Ministry of Health has decided to extend the use of Pfizers vaccine against the new coronavirus (Covid-19) to all…
Pfizer (PFE) Dips More Than Broader Markets: What You Should Know
In the latest trading session, Pfizer (PFE) closed at $51.13, marking a -1.35% move from the previous day....…
Chinesen können sich in Hongkong mit BionTech boostern lassen
Hongkong (Reuters) - Chinesen können sich offenbar bald in Hongkong mit dem Impfstoff von BioNTech gegen Covid-19 boostern lassen.
Der…
Fact Check-Componente de remédio da Pfizer contra Covid-19 é usado para aumentar níveis de medicamento no sangue e não está relacionado a falso risco de vacinas
...Por Reuters Fact Check
26 Dez (Reuters)
…
EU-Kommission will wegen Impfstoff-Überschüssen mit Herstellern und Mitgliedstaaten beraten
Berlin (Reuters) - In der Europäischen Union wächst die Sorge vor einem milliardenteuren Überschuss an nicht benötigten Corona-Impfstoffen.
Die Kommission…
ORIC Rises on Team-Up With Pfizer for Multiple Myeloma Study
ORIC inks a collaboration deal with Pfizer for a phase II study evaluating ORIC-533 in combination with the latters elranatamab…
Orics stock rallies on multiple myeloma deal with Pfizer
Shares of Oric Pharmaceuticals Inc. soared about 56% in premarket trading on Thursday, the day after the company said…
ORIC Pharma Collaborates With Pfizer For Phase 2 Study Of ORIC-533 In Multiple Myeloma; Stock Up
NEW YORK CITY (dpa-AFX) - ORIC Pharmaceuticals Inc. (ORIC) said that it has reached a clinical development collaboration with Pfizer…
Pfizer (PFE) Gains But Lags Market: What You Should Know
Pfizer (PFE) closed at $51.66 in the latest trading session, marking a +0.66% move from the prior day....…
ORIC Pharmaceuticals surges 43% on Pfizer collaboration, investment
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
ORIC Pharmaceuticals Announces Clinical Development Collaboration with Pfizer for ORIC-533 in Multiple Myeloma and Concurrent $25 Million Equity Investment by Pfizer
ORIC and Pfizer have entered into a clinical development collaboration for a Phase 2 study of ORIC-533 in combination with…
Sanofi, Pfizer settle Zantac case in California
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Specialty Generics Global Market Report 2022: Ukraine-Russia War Impact
NEW YORK, Dec. 21, 2022 /PRNewswire/ -- Major players in the specialty generics market are Teva Pharmaceutical Industries Ltd, Endo…
Pfizer submits colitis drug application to FDA, EMA
Pfizer Inc. said Wednesday that the Food and Drug Administration and the European Medicines Agency accepted the new…
Pfizer: FDA And EMA Accept Etrasimod Regulatory Submissions For Ulcerative Colitis
NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) said Wednesday that the U.S. Food and Drug Administration has accepted for…
Drug price group slashes suggested price of Pfizer COVID treatment by 80%
...By Sriparna Roy and Michael Erman
(Reuters) - An influential......…
LianBio (LIAN) Up After Pfizer Opts in Rights to RSV Drug in China
As a result of Pfizers (PFE) opt-in for LianBios (LIAN) rights to develop RSV therapeutic candidate sisunatovir in Greater China,…
The Zacks Analyst Blog Highlights Berkshire Hathaway, Exxon Mobil, Pfizer, Charles Schwab and ABB
Berkshire Hathaway, Exxon Mobil, Pfizer, Charles Schwab and ABB are part of the Zacks top Analyst Blog....…
Welt zittert vor Corona-Welle in China - das Hilfe ablehnt
- von Andreas Rinke und Trevor Hunnicutt und Julie Steenhuysen
Berlin/Washington (Reuters) - Seit Tagen wächst bei Regierungen in Europa und…
Top Research Reports for Berkshire Hathaway, Exxon Mobil & Pfizer
Todays Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BR.B), Exxon Mobil Corporation (XOM)…
Pfizer to develop, commercialize RSV candidate sisunatovir in China, Singapore
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pfizer gains rights to experimental RSV treatment in China, Hong Kong, Macau and Singapore
Pfizer Inc. said Monday that it will help develop and commercialize sisunatovir, LianBio's experimental respiratory syncytial virus (RSV)…
European Union records 1,000 cases of vaccine myocarditis in children
A study released this Saturday (17) by the European Union reported the registration of 1,007 cases of inflammation of the…
LianBio: Pfizer Opts In to Commercialize RSV Candidate Sisunatovir in Greater China, Singapore
LianBio: Pfizer Opts In to Commercialize RSV Candidate Sisunatovir in Greater China, Singapore...…
Clinton-Backed Initiative Ships Pfizer Covid Drugs to Africa
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Twitter Suppressed Early COVID-19 Treatment Information And Vaccine Safety Concerns: Cardiologist
Twitter Suppressed Early COVID-19 Treatment Information And Vaccine Safety Concerns: Cardiologist
…